Building The Strongest Family

Chapter 404: LUCEM-9

It had been two months since the pivotal Osborn family meeting that turned everything on its head.

Two months since Arthur laid out his plan that would forever intertwine his family’s legacy with the fate of the world.

The memory of GENEBANE was beginning to fade. Hospitals that had once been overcrowded with sickly patients now sat in an unsettling quiet.

Emergency rooms, which had previously been scenes of fear and despair, were calm. Only faint remnants of the turmoil remained,empty oxygen tanks stacked up like trophies from a recently won battle.

As the weeks passed, life started to return to its regular pace. But what the public didn’t realize was that another wave was brewing, not of illness, but of healing.

Arthur had initially dreamed of a grand reveal: a press conference that would send shockwaves around the globe.

He imagined bright lights flooding a stage, with rows of cameras capturing a promise of hope for billions. In the end, though, he opted for a different approach.

He simply told Emily, "Miracles shouldn’t be announced; they should manifest on their own."

And so, the breakthrough cancer treatment was released quietly,no grand celebrations, no flashy advertisements, no ostentatious countdowns. Just a brief notice in medical journals,a single press release buried under the usual updates from the pharmaceutical sector.

Osborn Pharmaceutical and Biotech Group announced the global rollout of LUCEM-9, validated as effective against various types of cancer.

At first, it went unnoticed. The press release sounded routine, and the medical community barely gave it a second glance.

Then, everything changed.

A private hospital in Noctis reported miraculous results: all thirty-two patients who received LUCEM-9 went into total remission within just seventy-two hours.

Soon after, another report surfaced from Zephyria about a boy with terminal bone cancer who was completely cured after only two doses. Then news emerged from another country,breast cancer remission rates hitting a staggering 100 percent.

In less than a week, LUCEM-9 was everywhere. It started on niche science blogs and health forums before going viral on social media. By the end of the week, it was making headlines across major networks in Panterra:

THE MIRACLE DRUG HAS ARRIVED.

CANCER IS NO MORE.

THE OSBORNS HAVE DONE IT AGAIN.

News anchors struggled to maintain their composure, their wide eyes revealing amazement even as they attempted to share the news calmly.

Networks replayed old footage of Arthur Osborn during moments captured in conference rooms and laboratories.

Analysts likened him to every savior imaginable,a modern-day messiah transforming the landscape of human health with every new discovery.

Inside Dominion Sanctum, the grand Osborn estate, the blue holographic light from Evolon illuminated the study. Evolon spoke in its steady, factual manner, yet beneath its surface lay an overwhelming amount of information.

"Global remission rate for the first week: ninety-seven percent," Evolon reported. "The rate of cure distribution is doubling every forty-eight hours. Oncology wards are reporting mass discharge events; hospitals are requesting resupply at double the anticipated rate."

Arthur sat at his desk, clad in the gray shirt he’d put on that morning. His tie hung loosely around his neck, sleeves rolled up. A smile was nowhere to be found.

Evolon continued its analysis: "Pharmaceutical index volatility is extremely high. The Global Health Market has plummeted fourteen percent in the past six hours, led by declines in oncology companies. Several firms are facing significant risk of collapse."

Leaning back in his chair, Arthur fixated on the holographic charts. Lines that had once signified profit and superiority for many corporations were now diving sharply.

"Show me the five biggest casualties," he requested quietly.

Evolon displayed the list:

Helix Global – 49.7% drop.

Aetheris Medical – 41%.

NexGen BioSolutions – 37%.

Pandora Health – 33%.

BioVertex International – 29%.

In a single day, five medical giants were beginning to stumble.

Arthur let out a slow breath. "And how is the public reacting?"

Evolon switched to another feed,a montage of reactions from across the world.

In the heart of Aurelia, crowds gathered in the city squares, embracing one another and shedding tears.

Meanwhile, in Verdania, a television news anchor broke down on live television as she recounted her sister’s journey to recovery. In Noctis, doctors stood outside hospitals, arms raised in unison, chanting the company’s name.

Even in nations where Osborn products had once faced strict bans or regulations, black markets were overwhelmed with shipments of LUCEM-9. The surge in demand was so overwhelming that governments had to quickly approve emergency imports in a matter of hours.

Evolon spoke in a monotone, as if disconnected from the information: "The public trust index for the Osborn Family is at a remarkable 98.4 percent approval across Panterra,the highest ever recorded for any institution in modern history."

Arthur took in the information, his expression unreadable.

He was aware this was merely the start: first came appreciation, then reverence, and ultimately, dependence.

Garrick Thorne president of Osborn Pharmaceutical and Biotech Group knoced on the door and walked in silently, carrying a glass tablet filled with market analytics and industrial charts.

"It’s spreading quicker than we expected," he remarked. "The Foundation clinics are running around the clock. Supply chains are holding up for now, but we anticipate a second wave of demand in the next forty-eight hours."

Arthur continued to focus on the screens, nodding slightly. "And how’s the infrastructure holding up?"

"Stable, but it’s becoming strained," Garrick replied. "We’ll need to ramp up drone capacity by thirty percent if this pace keeps up; Hivemind’s logistics network is already stretched thin."

Garrick managed a small, dry smile. "I did. I just didn’t expect it to unfold this rapidly. The world is in desperate need of hope, and you’ve provided it. They’ll cling to it tightly."

Emily and Nathaniel walked in next, Emily demeanor as sharp as ever.

She held a tablet that displayed an incessant flow of news updates. "The media has turned this into a phenomenon," she remarked. "Every talk show, every article, every influencer,everyone is expressing their gratitude. I’ve already received six offers from governments for exclusive interviews, but I’ve politely declined them for now."